|
Terren Peizer founded Hythiam in 2003. Recognizing that advances in scientific research definitively established alcohol and drug addiction as physiological chronic diseases not psychological sociological or personality disorders Peizer launched Hythiam.
Prior to forming Hythiam Peizer founded and served as Chairman and CEO of Clearant Inc. a biotechnology company that is a leader in pathogen inactivation solutions. Peizer has served as President and Vice Chairman of Hollis-Eden Pharmaceuticals and Chairman of the Board of Cray Inc. the supercomputing industry leader. He remains the largest beneficial shareholder of Cray Inc. He also has been among the largest beneficial shareholders and senior executives at several other technology and biotechnology companies.
Peizer has assisted companies with assembling management teams boards of directors and scientific advisory boards and formulating business and financial strategies including investor and public relations and capital formation. Peizer has a background in venture capital mergers and acquisitions investing and corporate finance. He held senior executive positions with the investment banking firms Goldman Sachs First Boston and Drexel Burnham Lambert. | 